Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
478 |
|
|||
481 |
|
|||
485 |
|
Pathway Name | Organism |
---|---|
Signaling by ALK fusions and activated point mutants | Homo sapiens |
Signaling by CSF1 (M-CSF) in myeloid cells | Homo sapiens |
Signaling by LTK | Homo sapiens |
Signaling by LTK in cancer | Homo sapiens |
Signaling by PDGFRA extracellular domain mutants | Homo sapiens |
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | Homo sapiens |
Synthesis of PIPs at the plasma membrane | Homo sapiens |
Tie2 Signaling | Homo sapiens |
VEGFA-VEGFR2 Pathway | Homo sapiens |
DO ID | Disease Name | Source |
---|---|---|
DOID:0050865 | tongue squamous cell carcinoma | |
DOID:0050873 | follicular lymphoma | |
DOID:0050888 | syndromic intellectual disability | |
DOID:0050902 | medulloblastoma | |
DOID:0050908 | myelodysplastic syndrome | |
DOID:0060022 | CD40 ligand deficiency | |
DOID:0060041 | autism spectrum disorder | |
DOID:0060058 | lymphoma | |
DOID:0060060 | non-Hodgkin lymphoma | |
DOID:0060061 | primary cutaneous T-cell non-Hodgkin lymphoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024